Monitored Therapeutics, Inc. (MTI) is a respiratory technology company headquartered in Dublin, Ohio, that provides FDA-cleared lung testing and remote monitoring solutions.
Subscribe to see Monitored Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Monitored Therapeutics, Inc. is a healthcare company headquartered in Dublin, United States. It has raised at least $8.4M across the 2 funding rounds on record. Its most recent funding round raised $4.3M in July 2021. Xcout tracks 7 named people at Monitored Therapeutics, Inc., including Whit Champagne (CEO).
As of 16 November 2026. Source: Xcout Intel.
1 more named person on record for Monitored Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $8.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.3M | — | |
| SEC Form D filing | $4.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Monitored Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Clairways is a medical device company headquartered in Lebanon, New Hampshire. It develops wearable smart lung monitor solutions designed to assist patients with conditions such as asthma and COPD.
FindAir is a medical technology company that manufactures smart inhaler devices and connected sensors for asthma and COPD remote monitoring and adherence tracking. The company is headquartered in Cracow, Poland.
Monitra Health is a digital healthcare company headquartered in Hyderabad, India, specializing in advanced wireless cardiac and Holter monitoring solutions. The company develops continuous patient monitoring tools designed to assist in cardiology care.
PneumoWave is a UK medical-technology company developing wearable, non-invasive respiratory monitoring devices. Its technology is intended to detect respiratory depression, particularly in patients receiving opioid medicines, for use by healthcare providers in clinical and community settings.
Biometry Inc. provides breathalyzer technology, software, and predictive analytics, focusing particularly on asthma and COPD management.
Pneumonics, Inc. develops PneuMotion, a continuous respiratory monitoring and obstructive apnea detection technology designed to detect opioid-induced ventilation impairment. The system integrates into hospital networks for mobile monitoring and electronic health record data collection, and also offers at-home overdose monitoring with automated emergency alerts.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Monitored Therapeutics, Inc.? Suggest a correction · Work at Monitored Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.